Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2014 Filed Jun 30, 2014 20:23 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,226 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-14-015767 · doc4.xml · derivative · entry 6 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,226 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2014 Filed Jun 30, 2014 20:23 UTC |
Deese Willie AExe V-P & Pres. MMD
|
SaleCommon Stock | 72,290 | $58.26 | $4,211,253.95 |
DisclosureSEC source: 0001225208-14-015767 · doc4.xml · nonDerivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,222.3873 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.9600 to $58.5200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 27, 2014 Filed Jun 30, 2014 20:23 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 7,226 | $31.84 | $230,075.84 |
DisclosureSEC source: 0001225208-14-015767 · doc4.xml · nonDerivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,512.3873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2014 Filed Jun 30, 2014 20:23 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 22,108 | $35.09 | $775,769.72 |
DisclosureSEC source: 0001225208-14-015767 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,286.3873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2014 Filed Jun 30, 2014 20:23 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 42,956 | $23.45 | $1,007,318.20 |
DisclosureSEC source: 0001225208-14-015767 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,178.3873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2014 Filed Jun 11, 2014 18:19 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,334 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-14-014834 · doc4.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,998 Underlying: Common Stock · 9,334 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2014 Filed Jun 11, 2014 18:19 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,542 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-14-014834 · doc4.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,874 Underlying: Common Stock · 3,542 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2014 Filed Jun 11, 2014 18:19 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 9,985 | $58.06 | $579,753.06 |
DisclosureSEC source: 0001225208-14-014834 · doc4.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,598.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.9600 to $58.2700, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 10, 2014 Filed Jun 11, 2014 18:19 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 3,542 | $31.84 | $112,777.28 |
DisclosureSEC source: 0001225208-14-014834 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,583.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2014 Filed Jun 11, 2014 18:19 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 9,334 | $35.09 | $327,530.06 |
DisclosureSEC source: 0001225208-14-014834 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,041.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 16:59 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014278 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,599.9226 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:00 UTC |
Cech Thomas RDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014279 · doc4.xml · derivative · entry 2 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,115.1206 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:00 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014280 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,344.8256 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014281 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,876.8996 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC |
KIDDER C ROBERTDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014282 · doc4.xml · derivative · entry 3 KIDDER C ROBERT · CIK 0001179703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,684.4106 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014283 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,765.2016 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC |
REPRESAS CARLOS EDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014284 · doc4.xml · derivative · entry 3 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,130.0346 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:01 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014285 · doc4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,684.4106 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:02 UTC |
Thompson Craig B.Director
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014286 · doc4.xml · derivative · entry 2 Thompson Craig B. · CIK 0001423419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,684.4086 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:02 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014287 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,496.1996 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 30, 2014 Filed Jun 3, 2014 17:02 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 2,592.4646 | $57.86 | $150,000.00 |
DisclosureSEC source: 0001225208-14-014288 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,780.9986 Underlying: Common Stock · 2,592.4646 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 14, 2014 Filed May 14, 2014 18:48 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
SaleCommon Stock | 10,527 | $55.91 | $588,583.52 |
DisclosureSEC source: 0001225208-14-012950 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.7800 to $56.1400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:52 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantStock Option (right to buy) · Derivative | 27,510 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012814 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 Underlying: Common Stock · 27,510 shares Expires 2024-05-08 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:52 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 2,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-012814 · doc4.xml · derivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 Underlying: Common Stock · 2,576 shares Expires 2017-05-09 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:52 UTC |
Davis Robert MExec V-P & Chief Fince Officer
|
GrantStock Option (right to buy) · Derivative | 192,572 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012815 · doc4.xml · derivative · entry 2 Davis Robert M · CIK 0001363076 · Exec V-P & Chief Fince Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,572 Underlying: Common Stock · 192,572 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:52 UTC |
Davis Robert MExec V-P & Chief Fince Officer
|
GrantRestricted Stock Unit · Derivative | 85,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-012815 · doc4.xml · derivative · entry 1 Davis Robert M · CIK 0001363076 · Exec V-P & Chief Fince Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,881 Underlying: Common Stock · 85,881 shares Expires 2017-05-09 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:53 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 82,531 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012816 · doc4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,531 Underlying: Common Stock · 82,531 shares Expires 2024-05-08 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:53 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantStock Option (right to buy) · Derivative | 60,523 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012817 · doc4.xml · derivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,523 Underlying: Common Stock · 60,523 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:53 UTC |
Golestani ClarkEVP & Chief Info Officer
|
GrantStock Option (right to buy) · Derivative | 41,265 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012818 · doc4.xml · derivative · entry 4 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,265 Underlying: Common Stock · 41,265 shares Expires 2024-05-08 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:53 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 93,535 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012819 · doc4.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,535 Underlying: Common Stock · 93,535 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:53 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantStock Option (right to buy) · Derivative | 60,523 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012820 · doc4.xml · derivative · entry 2 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,523 Underlying: Common Stock · 60,523 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:54 UTC |
Holston Michael JEVP, Chief Ethics & Compl Ofcr
|
GrantStock Option (right to buy) · Derivative | 55,021 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012821 · doc4.xml · derivative · entry 1 Holston Michael J · CIK 0001390613 · EVP, Chief Ethics & Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,021 Underlying: Common Stock · 55,021 shares Expires 2024-05-08 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantStock Option (right to buy) · Derivative | 27,510 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012822 · doc4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 Underlying: Common Stock · 27,510 shares Expires 2024-05-08 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantRestricted Stock Unit · Derivative | 2,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-012822 · doc4.xml · derivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 Underlying: Common Stock · 2,576 shares Expires 2017-05-09 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantStock Option (right to buy) · Derivative | 126,547 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012823 · doc4.xml · derivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,547 Underlying: Common Stock · 126,547 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 192,572 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012824 · doc4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,572 Underlying: Common Stock · 192,572 shares Expires 2024-05-08 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 41,265 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012825 · doc4.xml · derivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,265 Underlying: Common Stock · 41,265 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 209,078 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012826 · doc4.xml · derivative · entry 3 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,078 Underlying: Common Stock · 209,078 shares Expires 2024-05-08 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 550,206 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · derivative · entry 7 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,206 Underlying: Common Stock · 550,206 shares Expires 2024-05-08 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 9, 2015. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,334 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,332 Underlying: Common Stock · 9,334 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,542 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,416 Underlying: Common Stock · 3,542 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 10,220 | $55.00 | $562,100.00 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,707.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 3,542 | $31.84 | $112,777.28 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,927.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2014 Filed May 13, 2014 19:56 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 9,334 | $35.09 | $327,530.06 |
DisclosureSEC source: 0001225208-14-012827 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,385.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,103 | $58.22 | $238,876.66 |
DisclosureSEC source: 0001225208-14-012262 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,103 shares Expires 2014-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Tax withholdingCommon Stock | 1,529 | $58.22 | $89,018.38 |
DisclosureSEC source: 0001225208-14-012262 · doc4.xml · nonDerivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,299.017 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionCommon Stock | 4,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-012262 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,828.017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,659 | $58.22 | $445,906.98 |
DisclosureSEC source: 0001225208-14-012263 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,659 shares Expires 2014-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Tax withholdingCommon Stock | 3,449 | $58.22 | $200,800.78 |
DisclosureSEC source: 0001225208-14-012263 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,222.3873 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2014 Filed May 6, 2014 20:01 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 7,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-012263 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,671.3873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.